Catalyst Pharmaceuticals
CPRX
$14.89
Share price
1.43%
Change (1 day)
-5.52%
Change (1 year)
Categories
EPS for Catalyst Pharmaceuticals (CPRX)
EPS in 2023 (TTM): $1.10
According to Catalyst Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $1.10. In 2022 the company made an earnings per share (EPS) of $0.80 an increase over its 2021 EPS that were of $0.38.
EPS history for Catalyst Pharmaceuticals from 2004 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $1.10 | 37.5% |
| 2022 | $0.80 | 110.53% |
| 2021 | $0.38 | -47.22% |
| 2020 | $0.72 | 132.26% |
| 2019 | $0.31 | -191.18% |
| 2018 | -$0.34 | 54.55% |
| 2017 | -$0.22 | -4.35% |
| 2016 | -$0.23 | -8% |
| 2015 | -$0.25 | 4.17% |
| 2014 | -$0.24 | -11.11% |
| 2013 | -$0.27 | 107.69% |
| 2012 | -$0.13 | -55.17% |
| 2011 | -$0.29 | 31.82% |
| 2010 | -$0.22 | -55.1% |
| 2009 | -$0.49 | -39.51% |
| 2008 | -$0.81 | 145.45% |
| 2007 | -$0.33 | -8.33% |
| 2006 | -$0.36 | -28.71% |
| 2005 | -$0.50 | 180.56% |
| 2004 | -$0.18 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | 1,180.48% | 🇺🇸 USA |
 Pfizer PFE | $1.86 | 69.09% | 🇺🇸 USA |
 Abbott Laboratories ABT | $2.97 | 170.20% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | -$7.83 | -811.82% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -$9.78 | -988.86% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.78 | -29.21% | 🇺🇸 USA |